Investor Relations

Overview & Strategy

SkinBioTherapeutics is a life sciences company focused on skin health. We are listed on the AIM market of the London Stock Exchange under the ticker SBTX. 

Our portfolio of products and services spans topical products, oral supplements, intellectual property for outlicensing, and manufacturing. We address skin health through two complementary routes: from the outside in, and from the inside out. Together, these approaches create a scalable portfolio that supports skin function at every layer.  

Our brands include Dermatonics, a clinically trusted topical range with over 15 years of heritage in foot and hand care; AxisBiotix, a consumer food supplement that targets skin health through the gut-skin axis; intellectual property around SkinBiotix, and Bio-Tech Solutions is our manufacturing division, which gives the group end-to-end production capability.  

For all investor enquiries, contact us at ir@skinbiotix.com. 

LSE : SBTX
SkinBioTherapeutics PLC
Loading...

Registered Office

SkinBioTherapeutics plc is a company incorporated in England and Wales under the Companies Act 2006 with company number 09632164. The Company’s main country of operations is the United Kingdom.

SkinBioTherapeutics plc
Unit 75, Windmill Works, Warfield Road, Kelleythorpe Industrial Estate, Driffield, East Yorkshire, YO25 9FQ.

+44 (0)191 495 7325